Tech Company Financing Transactions

Merrimack Pharmaceuticals Funding Round

Private investors participated in a $77 million capital raise for Merrimack Pharmaceuticals. The round was announced on 4/14/2011.

Transaction Overview

Announced On
4/14/2011
Transaction Type
Venture Equity
Amount
$77,000,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds from the financing will be used to advance Merrimack's proprietary pipeline of novel targetedcancer therapeutics.

Company Information

Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
1 Kendall Sq. 14th Floor B7201
Cambridge, MA 02139
USA
Email Address
Overview
Merrimack Pharmaceuticals, Inc. (NASDAQ: MACK) is a biotechnology company based in Cambridge, Massachusetts. We are dedicated to the discovery and development of innovative therapies for the treatment of autoimmune disease and cancer.
Profile
Merrimack Pharmaceuticals LinkedIn Company Profile
Social Media
Merrimack Pharmaceuticals Company Twitter Account
Company News
Merrimack Pharmaceuticals News
Facebook
Merrimack Pharmaceuticals on Facebook
YouTube
Merrimack Pharmaceuticals on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Robert Mulroy
  Robert Mulroy LinkedIn Profile  Robert Mulroy Twitter Account  Robert Mulroy News  Robert Mulroy on Facebook
Chief Financial Officer
Yasir Al-Wakeel
  Yasir Al-Wakeel LinkedIn Profile  Yasir Al-Wakeel Twitter Account  Yasir Al-Wakeel News  Yasir Al-Wakeel on Facebook
VP - Bus. Development
Peter Laivins
  Peter Laivins LinkedIn Profile  Peter Laivins Twitter Account  Peter Laivins News  Peter Laivins on Facebook
VP - General Counsel
Jeffrey Munsie
  Jeffrey Munsie LinkedIn Profile  Jeffrey Munsie Twitter Account  Jeffrey Munsie News  Jeffrey Munsie on Facebook
VP - Operations
William Mcclements
  William Mcclements LinkedIn Profile  William Mcclements Twitter Account  William Mcclements News  William Mcclements on Facebook


 

 

Browse more venture capital transactions:

Prev: 4/14/2011: Ioxus venture capital transaction
Next: 4/14/2011: SilverRail Technologies venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to record all VC transactions involving tech companies. VC transactions reported here are sourced from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary